ストックスクリーナーアプリを入手
1.23
22.64%
-0.36
プレマーケット:
1.25
0.02
+1.63%
Traws Pharma Inc (TRAW) 最新ニュース
Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turn - GuruFocus
Traws Pharma (TRAW) Secures $60 Million Financing for Influenza Research - GuruFocus
Traws Pharma (NASDAQ: TRAW) pivots to antivirals amid TXM IND hold - Stock Titan
Traws Pharma Reports 2025 Results, Secures PIPE Financing - TipRanks
TRAWS PHARMA INC (NASDAQ:TRAW) Reports 2025 Earnings Beat Amid Dilutive $60M PIPE Financing and FDA Hold - ChartMill
TRAWS PHARMA ($TRAW) Releases Q4 2025 Earnings - Quiver Quantitative
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights - The Manila Times
Traws Pharma (NASDAQ: TRAW) raises up to $60M PIPE and funds runway into 2027 - Stock Titan
Traws Pharma, Inc. announced that it has received $10.009423 million in funding - marketscreener.com
Traws Pharma Secures Up to $60 Million PIPE Financing to Advance Influenza Drug Trial in the UK - Minichart
Traws Pharma prices $60M PIPE financing deal to fund UK flu trial - MSN
Traws Pharma secures $10M financing for influenza trial By Investing.com - Investing.com India
Traws Pharma Secures PIPE Financing for Influenza Trial - TipRanks
A $10M cash infusion aims to push Traws flu drug into a UK trial - Stock Titan
Traws Pharma (NASDAQ: TRAW) lines up $10M PIPE plus $50M in warrants - Stock Titan
Traws Pharma Delays 10-K Amid Financing Review - TipRanks
Charles Nolan Parker Net Worth (2026) - GuruFocus
hVIVO Lands Influenza Trial Deal - Vox Markets
hVIVO signs influenza human challenge trial contract with Traws Pharma - Vox Markets
Rate Hike: Should I set a stop loss on Traws Pharma Inc2026 Action & Verified Technical Trade Signals - baoquankhu1.vn
Resistance Check: Can Traws Pharma Inc stock outperform in a bear market2026 Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Levels: How do insiders feel about Traws Pharma IncEarnings Growth Report & Weekly Setup with ROI Potential - baoquankhu1.vn
Traws Pharma (TRAW) CFO receives new RSU and stock option grants - Stock Titan
Traws Pharma (TRAW) CFO Parker Nolan listed as insider in Form 3 - Stock Titan
Traws Pharma, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo
TRAW PE Ratio & Valuation, Is TRAW Overvalued - Intellectia AI
Traws Pharma Inc. (TRAW) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Traws Pharma (TRAW) delays 2025 Form 10-K, cites financing and going-concern review - Stock Titan
Traws Pharma Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Traws Pharma Inc expected to post a loss of $1.22 a shareEarnings Preview - TradingView
Published on: 2026-03-23 16:58:08 - baoquankhu1.vn
Traws Pharma (TRAW) Expected to Announce Earnings on Monday - Defense World
Aug Weekly: Whats the analyst consensus on Traws Pharma IncMarket Risk Analysis & High Win Rate Trade Tips - baoquankhu1.vn
Traws Pharma reports phase 2 COVID-19 data, flu program update - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Experimental COVID Pill Shows Edge Over Paxlovid as Traws Hits Key Milestones - MSN
Director at Traws Pharma (TRAW) receives grant of 33,435 stock options - Stock Titan
Traws Pharma (TRAW) director granted 31,258 stock options at $1.60 - Stock Titan
Traws Pharma (TRAW) director granted 33,435 stock options at $1.60 strike - Stock Titan
Traws Pharma (TRAW) awards CEO 231,336 stock options at $1.60 - Stock Titan
Traws Pharma (TRAW) awards 118,367 stock options to Chief Science Officer - Stock Titan
Traws Pharma (TRAW) COO receives grant of 96,899 stock options at $1.60 - Stock Titan
Traws Pharma (TRAW) awards 33,435 stock options to director Jack Stover - Stock Titan
Traws Pharma (TRAW) CMO awarded 108,854 stock options at $1.60 - Stock Titan
Traw Pharma director granted 33,435 stock options | TRAW SEC FilingForm 4 - Stock Titan
Will Traws Pharma Inc. (0T20) stock draw ESG focused fundsWeekly Profit Summary & High Accuracy Investment Signals - Naître et grandir
TRAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cash per share of Traws Pharma, Inc. – FWB:0T20 - TradingView
TRAW SEC FilingsTraws Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Traws Pharma Reports Phase 2 COVID-19 Data, Flu Program Update - MyChesCo
Traws Pharma (NASDAQ:TRAW) Trading Down 11.2% – Here’s What Happened - Defense World
Insider Sell: How much upside does Traws Pharma Inc haveTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Latest TRAW NewsTraws Pharma Announces Positive Topline Pha... - Stock Titan
Traws Pharma Reports Differentiated COVID-19 and Influenza Antiviral Progress - Contagion Live
Traws Pharma stock tumbles after FDA places tivoxavir marboxil on clinical hold By Investing.com - Investing.com South Africa
Traws Pharma stock tumbles after FDA places tivoxavir marboxil on clinical hold - Investing.com
Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data - TipRanks
Traws Pharma Stock Plunges As FDA Halts TXM IND - RTTNews
Traws Pharma completes Phase 2 ratutrelvir analysis; tivoxavir tablet shows 28-day influenza protection potential - TradingView
Traws Pharma completes analysis of ratutrelvir clinical study in Paxlovid®-eligible and ineligible Covid-19 patients - marketscreener.com
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):